Comparison of higher energy collisional dissociation and collision-induced dissociation MS/MS sequencing methods for identification of naturally occurring peptides in human urine

Proteomics - Clinical Applications

Volumn 9, Issue 5-6, 2015, Pages 531-542

  Pejchinovski, Martin ^a,b   Klein, Julie ^b   Ramírez Torres, Adela ^b   Bitsika, Vasiliki ^c   Mermelekas, George ^c   Vlahou, Antonia ^c   Mullen, William ^d   Mischak, Harald ^b,d   Jankowski, Vera ^e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MOSAIQUES DIAGNOSTICS GMBH   (Germany)

^c Academy of Athens Biomedical Research Foundation   (Greece)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Biomarkers; Clinical proteomics; MS MS sequencing; Peptide fragments

Indexed keywords

ACCURACY; ALGORITHM; AMINO ACID SEQUENCE; ANALYTIC METHOD; ARTICLE; COLLISIONALLY ACTIVATED DISSOCIATION; HIGHER ENERGY COLLISIONAL DISSOCIATION; HUMAN; INTERMETHOD COMPARISON; MASS SPECTROMETRY; PRIORITY JOURNAL; PROBABILITY; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEOMICS; REPRODUCIBILITY; SEQUENCE ANALYSIS; URINALYSIS; CHEMISTRY; COMPARATIVE STUDY; MOLECULAR GENETICS; PROCEDURES; TANDEM MASS SPECTROMETRY; URINE;

PEPTIDE FRAGMENT;

AMINO ACID SEQUENCE; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; REPRODUCIBILITY OF RESULTS; SEQUENCE ANALYSIS, PROTEIN; TANDEM MASS SPECTROMETRY; URINALYSIS;

EID: 84930894478     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201400163     Document Type: Article

References (44)

1. Mischak, H., Ioannidis, J. P., Argiles, A., Attwood, T. K. et al., Implementation of proteomic biomarkers: making it work. Eur. J. Clin. Invest. 2012, 42, 1027-1036.
2. Coon, J. J., Zürbig, P., Dakna, M., Dominiczak, A. F. et al., CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clin. Appl. 2008, 2, 964-973.
3. Good, D. M., Zürbig, P., Argiles, A., Bauer, H. W. et al., Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol. Cell Proteomics 2010, 9, 2424-2437.
4. Mischak, H., Schanstra, J. P., CE-MS in biomarker discovery, validation, and clinical application. Proteomics Clin. Appl. 2011, 5, 9-23.
5. Rodriguez-Suarez, E., Siwy, J., Zurbig, P., Mischak, H., Urine as a source for clinical proteome analysis: from discovery to clinical application. Biochim. Biophys. Acta 2014, 5, 884-898.
6. Metzger, J., Negm, A. A., Plentz, R. R., Weismuller, T. J. et al., Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders. Gut 2013, 1, 122-130.
7. Roscioni, S. S., de, Z. D., Hellemons, M. E., Mischak, H. et al., A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus. Diabetologia 2012, 56, 259-267.
8. Theodorescu, D., Schiffer, E., Bauer, H. W., Douwes, F. et al., Discovery and validation of urinary biomarkers for prostate cancer. Proteomics Clin. Appl. 2008, 2, 556-570.
9. Klein, J., Eales, J., Zurbig, P., Vlahou, A. et al., Proteasix: a tool for automated and large-scale prediction of proteases involved in naturally occurring peptide generation. Proteomics 2013, 13, 1077-1082.
10. Guthals, A., Bandeira, N., Peptide identification by tandem mass spectrometry with alternate fragmentation modes. Mol. Cell Proteomics 2012, 11, 550-557.
11. Klein, J., Papadopoulos, T., Mischak, H., Mullen, W., Comparison of CE-MS/MS and LC-MS/MS sequencing demonstrates significant complementarity in natural peptide identification in human urine. Electrophoresis 2014, 35, 1060-1064.
12. Olsen, J. V., Ong, S. E., Mann, M., Trypsin cleaves exclusively C-terminal to arginine and lysine residues. Mol. Cell Proteomics 2004, 3, 608-614.
13. Kraj, A., Brouwer, H. J., Reinhoud, N., Chervet, J. P., A novel electrochemical method for efficient reduction of disulfide bonds in peptides and proteins prior to MS detection. Anal. Bioanal. Chem. 2013, 405, 9311-9320.
14. Mormann, M., Eble, J., Schwoppe, C., Mesters, R. M. et al., Fragmentation of intra-peptide and inter-peptide disulfide bonds of proteolytic peptides by nanoESI collision-induced dissociation. Anal. Bioanal. Chem. 2008, 392, 831-838.
15. Second, T. P., Blethrow, J. D., Schwartz, J. C., Merrihew, G. E. et al., Dual-pressure linear ion trap mass spectrometer improving the analysis of complex protein mixtures. Anal. Chem. 2009, 81, 7757-7765.
16. Shen, Y., Tolic, N., Purvine, S. O., Smith, R. D., Improving collision induced dissociation (CID), high energy collision dissociation (HCD), and electron transfer dissociation (ETD) fourier transform MS/MS degradome-peptidome identifications using high accuracy mass information. J. Proteome. Res. 2012, 11, 668-677.
17. Jedrychowski, M. P., Huttlin, E. L., Haas, W., Sowa, M. E. et al., Evaluation of HCD- and CID-type fragmentation within their respective detection platforms for murine phosphoproteomics. Mol. Cell Proteomics 2011, 10, M111.
18. Olsen, J. V., Schwartz, J. C., Griep-Raming, J., Nielsen, M. L. et al., A dual pressure linear ion trap Orbitrap instrument with very high sequencing speed. Mol. Cell Proteomics 2009, 8, 2759-2769.
19. Wiesner, J., Premsler, T., Sickmann, A., Application of electron transfer dissociation (ETD) for the analysis of posttranslational modifications. Proteomics 2008, 8, 4466-4483.
20. Frese, C. K., Altelaar, A. F., Hennrich, M. L., Nolting, D. et al., Improved peptide identification by targeted fragmentation using CID, HCD and ETD on an LTQ-Orbitrap Velos. J. Proteome. Res. 2011, 10, 2377-2388.
21. Olsen, J. V., Macek, B., Lange, O., Makarov, A. et al., Higher-energy C-trap dissociation for peptide modification analysis. Nat. Methods 2007, 4, 709-712.
22. Chi, H., Sun, R. X., Yang, B., Song, C. Q. et al., pNovo: de novo peptide sequencing and identification using HCD spectra. J. Proteome Res. 2010, 9, 2713-2724.
23. Kocher, T., Pichler, P., Schutzbier, M., Stingl, C. et al., High precision quantitative proteomics using iTRAQ on an LTQ Orbitrap: a new mass spectrometric method combining the benefits of all. J. Proteome Res. 2009, 8, 4743-4752.
24. Sarbu, M., Ghiulai, R. M., Zamfir, A. D., Recent developments and applications of electron transfer dissociation mass spectrometry in proteomics. Amino Acids 2014, 46, 1625-1634.
25. Klein J., Papadopoulos, T., Mischak, H., Mullen, W., Comparison of CE-MS/MS and LC-MS/MS sequencing demonstrates significant complementarity in natural peptide identification. Electrophoresis 2014, 35, 1060-1064.
26. Haubitz, M., Good, D. M., Woywodt, A., Haller H et al., Identification and validation of urinary biomarkers for differential diagnosis and dvaluation of therapeutic intervention in ANCA associated vasculitis. Mol. Cell. Proteomics 2009, 8, 2296-2307.
27. Jantos-Siwy, J., Schiffer, E., Brand, K., Schumann, G. et al., Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease. J. Proteome Res. 2009, 8, 268-281.
28. Kistler, A. D., Mischak, H., Poster, D., Dakna, M. et al., Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease. Kidney Int. 2009, 76, 89-96.
29. Zürbig, P., Schiffer, E., Mischak, H., Capillary electrophoresis coupled to mass spectrometry for proteomic profiling of human urine and biomarker discovery. Methods Mol. Biol. 2009, 564, 105-121.
30. Miseta, A., Csutora, P., Relationship between the occurrence of cysteine in proteins and the complexity of organisms. Mol. Biol. Evol. 2000, 17, 1232-1239.
31. Keller, A., Nesvizhskii, A. I., Kolker, E., Aebersold, R., Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 2002, 74, 5383-5392.
32. Siwy, J., Mullen, W., Golovko, I., Franke, J., Zürbig, P., Human urinary peptide database for multiple disease biomarker discovery. Proteomics Clin. Appl. 2011, 5, 367-374.
33. Mischak, H., Julian, B. A., Novak, J., High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine. Proteomics Clin. Appl. 2007, 1, 792-804.
34. Zheng, X., Baker, H., Hancock, W. S., Analysis of the low molecular weight serum peptidome using ultrafiltration and a hybrid ion trap-Fourier transform mass spectrometer. J. Chromatogr. A 2006, 1120, 173-184.
35. Yang, X., Hu, L., Ye, M., Zou, H., Analysis of the human urine endogenous peptides by nanoparticle extraction and mass spectrometry identification. Anal. Chim. Acta 2014, 829, 40-47.
36. Mann, M., Kelleher, N. L., Precision proteomics: the case for high resolution and high mass accuracy. Proc. Natl. Acad. Sci. USA 2008, 105, 18132-18138.
37. Li, Y. F., Radivojac, P., Computational approaches to protein inference in shotgun proteomics. BMC Bioinformatics 2012, 13, S4.
38. Jeong, K., Kim, S., Bandeira, N., False discovery rates in spectral identification. BMC Bioinformatics 2012, 13, S2.
39. Zhang, H., Yi, E. C., Li, X. J., Mallick, P. et al., High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spectrometry. Mol. Cell Proteomics 2005, 4, 144-155.
40. Hart, S. R., Lau, K. W., Gaskell, S. J., Hubbard, S. J., Distributions of ion series in ETD and CID spectra: making a comparison. Methods Mol. Biol. 2011, 696, 327-337.
41. Kim, S., Mischerikow, N., Bandeira, N., Navarro, J. D. et al., The generating function of CID, ETD, and CID/ETD pairs of tandem mass spectra: applications to database search. Mol. Cell Proteomics 2010, 9, 2840-2852.
42. Molina, H., Matthiesen, R., Kandasamy, K., Pandey, A., Comprehensive comparison of collision induced dissociation and electron transfer dissociation. Anal. Chem. 2008, 80, 4825-4835.
43. Nagaraj, N., D'Souza, R. C., Cox, J., Olsen, J. V., Mann, M., Feasibility of large-scale phosphoproteomics with higher energy collisional dissociation fragmentation. J. Proteome Res. 2010, 9, 6786-6794.
44. Sleno, L., Volmer, D. A., Ion activation methods for tandem mass spectrometry. J. Mass Spectrom. 2004, 39, 1091-1112.